文献速递头颈部肿瘤放疗

头颈癌根治性放疗或放化疗患者报告毒性及生活质量特征

Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-05-26

该研究纳入2007至2017年接受根治性放疗(±系统治疗)的859例头颈癌患者,前瞻性定期填写EORTC QLQ-HN35和QLQ-C30问卷至5年。患者分为早期喉癌、舌骨下癌和舌骨上癌三组,症状评分在治疗期间升高、随后2年内逐渐恢复,三组毒性特征不同(P < .001),早期喉癌组症状较轻。

要点

  • 头颈癌根治性放疗期间患者报告症状加重,治疗后2年内逐渐恢复。
  • 早期喉癌、舌骨下癌和舌骨上癌三组毒性特征显著不同(P < .001)。
  • 早期喉癌组症状评分普遍较轻,角色功能、食欲减退、疲乏和疼痛差异最明显。

核心结论

  • 建立了头颈癌三个亚组患者报告毒性和生活质量的轮廓,显示不同模式,可指导未来患者治疗并作为研究基准。

研究设计与样本

  • 前瞻性队列研究,纳入2007至2017年接受根治性放疗(±系统治疗)的859例头颈癌患者,按早期喉癌(157例)、舌骨下癌(304例)和舌骨上癌(398例)分组,定期填写EORTC QLQ-HN35和QLQ-C30问卷至5年,总体应答率83%。

主要发现

  • EORTC QLQ-HN35症状评分在治疗期间升高,随后2年内逐渐恢复。
  • 三个亚组毒性特征不同(P < .001),早期喉癌组症状评分普遍较轻。
  • EORTC QLQ-C30功能、生活质量和一般症状的时间模式较不明显,但组间差异仍显著(P < .001),角色功能、食欲减退、疲乏和疼痛的平均评分差异最明显。

关键数值与推荐

  • EORTC QLQ-HN35症状评分在治疗期间升高,随后2年内逐渐恢复。
  • 三个亚组毒性特征不同(P < .001),早期喉癌组症状评分普遍较轻。
  • EORTC QLQ-C30功能、生活质量和一般症状的组间差异显著(P < .001),角色功能、食欲减退、疲乏和疼痛的平均评分差异最明显。

临床怎么用

  • 可利用这些患者报告毒性轮廓告知未来头颈癌患者的治疗预期。
  • 这些轮廓可作为未来研究的基准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation therapy is an effective but burdensome treatment for head and neck cancer (HNC). We aimed to characterize the severity and time pattern of patient-reported symptoms and quality of life in a large cohort of patients with HNC treated with definitive radiation therapy, with or without systemic treatment. METHODS AND MATERIALS: A total of 859 patients with HNC treated between 2007 and 2017 prospectively completed the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Head and Neck Cancer module (QLQ-HN35) and Core Quality of Life Questionnaire (QLQ-C30) at regular intervals during and after treatment for up to 5 years. Patients were classified into 3 subgroups: early larynx cancer, infrahyoideal cancer, and suprahyoideal cancer. Outcome scales of both questionnaires were quantified per subgroup and time point by means of average scores and the frequency distribution of categorized severity (none, mild, moderate, and severe). Time patterns and symptom severity were characterized. Toxicity profiles were compared using linear mixed model analysis. Additional toxicity profiles based on age, human papillomavirus status, treatment modality, smoking status, tumor site, and treatment period were characterized as well. RESULTS: The study population consisted of 157 patients with early larynx cancer, 304 with infrahyoideal cancer, and 398 with suprahyoideal cancer. The overall questionnaire response rate was 83%. Generally, the EORTC QLQ-HN35 symptoms reported showed a clear time pattern, with increasing scores during treatment followed by a gradual recovery in the first 2 years. Distinct toxicity profiles were seen across subgroups (P < .001), with generally less severe symptom scores in the early larynx subgroup. The EORTC QLQ-C30 functioning, quality-of-life, and general symptoms reported showed a less evident time pattern and less pronounced differences in mean scores between subgroups, although differences were still significant (P < .001). Differences in mean scores were most pronounced for role functioning, appetite loss, fatigue, and pain. CONCLUSIONS: We established patient-reported toxicity and quality-of-life profiles that showed different patterns for 3 subgroups of patients with HNC. These profiles provide detailed information on the severity and persistence of various symptoms as experienced by patients during and after definitive radiation therapy. These profiles can be used to inform treatment of future patients and may serve as a benchmark for future studies.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Van den Bosch L, van der Laan HP, van der Schaaf A, et al. Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation. Int J Radiat Oncol Biol Phys. 2021. PMID: 34048816. doi:10.1016/j.ijrobp.2021.05.114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。